Bristol-Myers Squibb Company (BMY) Shares Outstanding 2006–TTM

Name: Bristol-Myers Squibb Company (BMY) shares outstanding history 2006-TTM
Creator: TickerBase

DATA UPDATED 2026-07-13

Bristol-Myers Squibb Company annual shares outstanding for fiscal TTM was 2,044 million shares, an increase of 0.1% from 2,041 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

BMY Annual Shares Outstanding

Shares Outstanding (annual)	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Shares Outstanding (M)	2,044M	2,041M	2,027M	2,078M	2,146M	2,245M	2,258M	1,712M	1,637M	1,652M	1,680M	1,679M	1,670M	1,662M	1,688M	1,717M	1,727M	1,978M	2,001M	1,980M	1,963M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BMY Quarterly Shares Outstanding

Shares Outstanding (quarterly)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Shares Outstanding (M)	2,044M	2,041M	2,038M	2,038M	2,037M	2,037M	2,031M	2,029M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More BMY metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All BMY financial statements → Interactive BMY charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.